<!DOCTYPE html>
<html>
<head>
    <meta charset="utf-8">
    <title>COVID-19 vaccines adverse events: myocarditis, pericarditis, etc. (99 million people, not US)</title>
    <link rel="stylesheet" href="/css/main.css?v=1742566338">
    <link rel="stylesheet" href="/css/pagination.css?v=1742566338">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css">
    <script src="https://unpkg.com/lunr/lunr.js"></script>
    <script src="/js/search.js?v=1742566338"></script>
</head>
<body>
    <div class="container">
        <div class="sidebar">
            <h2>Search</h2>
            <div class="search-container">
                <input type="text" id="search-input" placeholder="Loading search index..." disabled>
                <div id="search-status" class="search-status">Loading search index...</div>
                <div id="suggestions" class="search-suggestions"></div>
            </div>
            <ul id="search-results"></ul>
            
            <h2>Categories</h2>
            <ul data-spa-nav>
                
                <li><a href="/categories/about-d---introduction/">About D - Introduction (3)</a></li>
                
                <li><a href="/categories/about-d---more-info./">About D - More Info. (3)</a></li>
                
                <li><a href="/categories/adhd/">ADHD (5)</a></li>
                
                <li><a href="/categories/admin-only/">Admin Only (5)</a></li>
                
                <li><a href="/categories/ai/">AI (31)</a></li>
                
                <li><a href="/categories/antibiotics-probiotics/">Antibiotics, Probiotics (4)</a></li>
                
                <li><a href="/categories/associations/">Associations (1)</a></li>
                
                <li><a href="/categories/autism/">Autism (10)</a></li>
                
                <li><a href="/categories/autoimmune/">Autoimmune (9)</a></li>
                
                <li><a href="/categories/back-pain/">Back Pain (3)</a></li>
                
                <li><a href="/categories/better-than-daily/">Better Than Daily (6)</a></li>
                
                <li><a href="/categories/bipolar/">Bipolar (1)</a></li>
                
                <li><a href="/categories/bone---health/">Bone - Health (12)</a></li>
                
                <li><a href="/categories/books-videos-on-vitamin-d/">Books, Videos on Vitamin D (28)</a></li>
                
                <li><a href="/categories/breathing/">Breathing (16)</a></li>
                
                <li><a href="/categories/calcidiol/">Calcidiol (2)</a></li>
                
                <li><a href="/categories/cancer/">Cancer (30)</a></li>
                
                <li><a href="/categories/cancer---after-diagnosis/">Cancer - After Diagnosis (12)</a></li>
                
                <li><a href="/categories/cancer---bladder/">Cancer - Bladder (2)</a></li>
                
                <li><a href="/categories/cancer---breast/">Cancer - Breast (13)</a></li>
                
                <li><a href="/categories/cancer---colon/">Cancer - Colon (8)</a></li>
                
                <li><a href="/categories/cancer---leukemia/">Cancer - Leukemia (1)</a></li>
                
                <li><a href="/categories/cancer---liver/">Cancer - Liver (1)</a></li>
                
                <li><a href="/categories/cancer---lung/">Cancer - Lung (1)</a></li>
                
                <li><a href="/categories/cancer---lymphoma/">Cancer - Lymphoma (1)</a></li>
                
                <li><a href="/categories/cancer---other/">Cancer - Other (7)</a></li>
                
                <li><a href="/categories/cancer---ovarian/">Cancer - Ovarian (2)</a></li>
                
                <li><a href="/categories/cancer---pancreatic/">Cancer - Pancreatic (1)</a></li>
                
                <li><a href="/categories/cancer---prostate/">Cancer - Prostate (4)</a></li>
                
                <li><a href="/categories/cancer---skin/">Cancer - Skin (5)</a></li>
                
                <li><a href="/categories/cardiovascular/">Cardiovascular (35)</a></li>
                
                <li><a href="/categories/category/">Category (1)</a></li>
                
                <li><a href="/categories/cholesterol/">Cholesterol (1)</a></li>
                
                <li><a href="/categories/cognitive/">Cognitive (34)</a></li>
                
                <li><a href="/categories/conference/">Conference (1)</a></li>
                
                <li><a href="/categories/consensus/">Consensus (3)</a></li>
                
                <li><a href="/categories/cost-savings-with-vitamin-d/">Cost Savings With Vitamin D (10)</a></li>
                
                <li><a href="/categories/curcumin/">Curcumin (1)</a></li>
                
                <li><a href="/categories/cyp27b1/">CYP27B1 (6)</a></li>
                
                <li><a href="/categories/cystic-fibrosis/">Cystic Fibrosis (2)</a></li>
                
                <li><a href="/categories/deficiency-of-vitamin-d/">Deficiency of Vitamin D (28)</a></li>
                
                <li><a href="/categories/dental/">Dental (18)</a></li>
                
                <li><a href="/categories/depression/">Depression (17)</a></li>
                
                <li><a href="/categories/diabetes/">Diabetes (23)</a></li>
                
                <li><a href="/categories/epilepsy/">Epilepsy (1)</a></li>
                
                <li><a href="/categories/evidence-for-d/">Evidence for D (7)</a></li>
                
                <li><a href="/categories/falls-and-fractures/">Falls and Fractures (21)</a></li>
                
                <li><a href="/categories/fertility-and-sperm/">Fertility and Sperm (10)</a></li>
                
                <li><a href="/categories/food-sources-for-vitamin-d/">Food Sources for Vitamin D (2)</a></li>
                
                <li><a href="/categories/forms-of-vitamin-d/">Forms of Vitamin D (8)</a></li>
                
                <li><a href="/categories/fortification-with-vitamin-d/">Fortification With Vitamin D (8)</a></li>
                
                <li><a href="/categories/genetics/">Genetics (19)</a></li>
                
                <li><a href="/categories/greger/">Greger (4)</a></li>
                
                <li><a href="/categories/gut/">Gut (13)</a></li>
                
                <li><a href="/categories/headache/">Headache (4)</a></li>
                
                <li><a href="/categories/health/">Health (14)</a></li>
                
                <li><a href="/categories/high-risk/">High Risk (3)</a></li>
                
                <li><a href="/categories/high-dose/">High-Dose (9)</a></li>
                
                <li><a href="/categories/how-much-vitamin-d/">How Much Vitamin D (4)</a></li>
                
                <li><a href="/categories/how-when-to-take-vit.-d/">How, When to Take Vit. D (4)</a></li>
                
                <li><a href="/categories/hypertension/">Hypertension (6)</a></li>
                
                <li><a href="/categories/immunity/">Immunity (13)</a></li>
                
                <li><a href="/categories/increased-use-of-d/">Increased Use of D (2)</a></li>
                
                <li><a href="/categories/infant-child/">Infant-Child (64)</a></li>
                
                <li><a href="/categories/inflammation/">Inflammation (12)</a></li>
                
                <li><a href="/categories/interactions-with-vitamin-d/">Interactions With Vitamin D (11)</a></li>
                
                <li><a href="/categories/intervention/">Intervention (39)</a></li>
                
                <li><a href="/categories/intervention---non-daily/">Intervention - Non Daily (21)</a></li>
                
                <li><a href="/categories/iodine/">Iodine (1)</a></li>
                
                <li><a href="/categories/kidney/">Kidney (7)</a></li>
                
                <li><a href="/categories/liver/">Liver (3)</a></li>
                
                <li><a href="/categories/loading-dose-for-vitamin-d/">Loading Dose for Vitamin D (9)</a></li>
                
                <li><a href="/categories/lupus/">Lupus (3)</a></li>
                
                <li><a href="/categories/meta-analysis-of-vitamin-d/">Meta-Analysis of Vitamin D (52)</a></li>
                
                <li><a href="/categories/metabolic-syndrome/">Metabolic Syndrome (10)</a></li>
                
                <li><a href="/categories/microbiome/">Microbiome (6)</a></li>
                
                <li><a href="/categories/middle-east/">Middle East (2)</a></li>
                
                <li><a href="/categories/mortality-and-d/">Mortality and D (23)</a></li>
                
                <li><a href="/categories/multiple-sclerosis/">Multiple Sclerosis (21)</a></li>
                
                <li><a href="/categories/noontime-sun-and-d/">Noontime Sun and D (11)</a></li>
                
                <li><a href="/categories/obesity/">Obesity (29)</a></li>
                
                <li><a href="/categories/off-topic/">Off Topic (5)</a></li>
                
                <li><a href="/categories/optimum/">Optimum (4)</a></li>
                
                <li><a href="/categories/orient/">Orient (4)</a></li>
                
                <li><a href="/categories/osteoarthritis/">Osteoarthritis (1)</a></li>
                
                <li><a href="/categories/osteoporosis/">Osteoporosis (13)</a></li>
                
                <li><a href="/categories/overview-for-doctors/">Overview for Doctors (1)</a></li>
                
                <li><a href="/categories/pain---chronic/">Pain - Chronic (8)</a></li>
                
                <li><a href="/categories/parkinson/">Parkinson (14)</a></li>
                
                <li><a href="/categories/patent/">Patent (1)</a></li>
                
                <li><a href="/categories/predict-vitamin-d/">Predict Vitamin D (3)</a></li>
                
                <li><a href="/categories/pregnancy/">Pregnancy (48)</a></li>
                
                <li><a href="/categories/psoriasis/">Psoriasis (5)</a></li>
                
                <li><a href="/categories/quality-of-life/">Quality of Life (3)</a></li>
                
                <li><a href="/categories/resveratrol/">Resveratrol (2)</a></li>
                
                <li><a href="/categories/rheumatoid-arthritis/">Rheumatoid Arthritis (6)</a></li>
                
                <li><a href="/categories/rickets/">Rickets (1)</a></li>
                
                <li><a href="/categories/season-of-birth/">Season of Birth (1)</a></li>
                
                <li><a href="/categories/seniors/">Seniors (27)</a></li>
                
                <li><a href="/categories/shut-in/">Shut-In (2)</a></li>
                
                <li><a href="/categories/skin/">Skin (8)</a></li>
                
                <li><a href="/categories/skin---dark/">Skin - Dark (9)</a></li>
                
                <li><a href="/categories/sleep/">Sleep (7)</a></li>
                
                <li><a href="/categories/sports-and-vitamin-d/">Sports and Vitamin D (10)</a></li>
                
                <li><a href="/categories/stroke/">Stroke (12)</a></li>
                
                <li><a href="/categories/supplement/">Supplement (4)</a></li>
                
                <li><a href="/categories/technical-d/">Technical D (1)</a></li>
                
                <li><a href="/categories/tests-for-vitamin-d/">Tests for Vitamin D (3)</a></li>
                
                <li><a href="/categories/thyroid-and-parathyroid/">Thyroid and Parathyroid (1)</a></li>
                
                <li><a href="/categories/top-news/">Top News (7)</a></li>
                
                <li><a href="/categories/toxicity-of-vitamin-d/">Toxicity of Vitamin D (1)</a></li>
                
                <li><a href="/categories/trauma-and-surgery/">Trauma and Surgery (15)</a></li>
                
                <li><a href="/categories/tuberculosis/">Tuberculosis (3)</a></li>
                
                <li><a href="/categories/uv-and-vitamin-d/">UV and Vitamin D (14)</a></li>
                
                <li><a href="/categories/veterinary-and-vitamin-d/">Veterinary and Vitamin D (4)</a></li>
                
                <li><a href="/categories/virus/">Virus (160)</a></li>
                
                <li><a href="/categories/vision/">Vision (14)</a></li>
                
                <li><a href="/categories/vit-d-binding-protein/">Vit D Binding Protein (8)</a></li>
                
                <li><a href="/categories/vitamin-b12/">Vitamin B12 (5)</a></li>
                
                <li><a href="/categories/vitamin-c/">Vitamin C (4)</a></li>
                
                <li><a href="/categories/vitamin-d-and-boron/">Vitamin D and Boron (6)</a></li>
                
                <li><a href="/categories/vitamin-d-and-calcium/">Vitamin D and Calcium (6)</a></li>
                
                <li><a href="/categories/vitamin-d-and-iron/">Vitamin D and Iron (3)</a></li>
                
                <li><a href="/categories/vitamin-d-and-magnesium/">Vitamin D and Magnesium (22)</a></li>
                
                <li><a href="/categories/vitamin-d-and-omega-3/">Vitamin D and Omega-3 (18)</a></li>
                
                <li><a href="/categories/vitamin-d-and-vitamin-a/">Vitamin D and Vitamin A (1)</a></li>
                
                <li><a href="/categories/vitamin-d-and-vitamin-k/">Vitamin D and Vitamin K (8)</a></li>
                
                <li><a href="/categories/vitamin-d-far-from-equator/">Vitamin D Far From Equator (4)</a></li>
                
                <li><a href="/categories/vitamin-d-in-australia-and-new-zealand/">Vitamin D in Australia and New Zealand (2)</a></li>
                
                <li><a href="/categories/vitamin-d-in-canada/">Vitamin D in Canada (2)</a></li>
                
                <li><a href="/categories/vitamin-d-in-europe/">Vitamin D in Europe (4)</a></li>
                
                <li><a href="/categories/vitamin-d-receptor/">Vitamin D Receptor (39)</a></li>
                
                <li><a href="/categories/vitamin-d3-instead-of-d2/">Vitamin D3 Instead of D2 (1)</a></li>
                
                <li><a href="/categories/women/">Women (13)</a></li>
                
                <li><a href="/categories/youth/">Youth (8)</a></li>
                
                <li><a href="/categories/zinc/">Zinc (6)</a></li>
                
            </ul>
        </div>
        <div class="content" role="main">
            
    <article>
        <h1>COVID-19 vaccines adverse events: myocarditis, pericarditis, etc. (99 million people, not US)</h1>
        <time>March 13, 2024</time>
        <!-- {maketoc Title=""} -->
<hr>
<h4 id="covid-19-vaccines-and-adverse-events-of-special-interest-a-multinational-global-vaccine-data-network-gvdn-cohort-study-of-99-million-vaccinated-individuals">COVID-19 vaccines and adverse events of special interest: A multinational Global Vaccine Data Network (GVDN) cohort study of 99 million vaccinated individuals</h4>
<p>Vaccine <a href="https://doi.org/10.1016/j.vaccine.2024.01.100">https://doi.org/10.1016/j.vaccine.2024.01.100</a></p>
<p>K. Faksova a, D. Walsh b c, Y. Jiang b c, J. Griffin c, A. Phillips d, A. Gentile e, J.C. Kwong f g h, K. Macartney d i, M. Naus j n, Z. Grange k, S. Escolano l, G. Sepulveda m, A. Shetty m, A. Pillsbury d, C. Sullivan k, Z. Naveed j n, N.Z. Janjua j n, N. Giglio e, J. Perälä o, S. Nasreen f p x…A. Hviid a w</p>
<p><strong>This summary is NOT in the PDF</strong></p>
<img src="/attachments/d3.mock.jpg" alt="image" width="300">
<p>Major color groups used for different pharmas:</p>
<p>    <span style="color:orange;">Red = Moderna</span>,  <span style="color:orange;">Blue = Pfizer,</span>  <span style="color:orange;">Amber = AstraZeneca</span></p>
<p>Shades within the groups related to different doses of the particular pharma&rsquo;s &ldquo;vaccine&rdquo;</p>
<img src="/attachments/d3.mock.jpg" alt="image" width="350">
<p>Background</p>
<p>The Global COVID Vaccine Safety (GCoVS) Project, established in 2021 under the multinational Global Vaccine Data Network™ (GVDN®), facilitates comprehensive assessment of vaccine safety. This study aimed to evaluate the risk of adverse events of special interest (AESI) following COVID-19 vaccination from 10 sites across eight countries.</p>
<p>Methods</p>
<p>Using a common protocol, this observational cohort study compared observed with expected rates of 13 selected AESI across neurological, haematological, and cardiac outcomes. Expected rates were obtained by participating sites using pre-COVID-19 vaccination healthcare data stratified by age and sex. Observed rates were reported from the same healthcare datasets since COVID-19 vaccination program rollout. AESI occurring up to 42 days following vaccination with mRNA (BNT162b2 and mRNA-1273) and adenovirus-vector (ChAdOx1) vaccines were included in the primary analysis. Risks were assessed using observed versus expected (OE) ratios with 95 % confidence intervals. Prioritised potential safety signals were those with  <strong>lower bound of the 95 % confidence interval (LBCI) greater than 1.5.</strong></p>
<p>Results</p>
<p>Participants included 99,068,901 vaccinated individuals. In total, 183,559,462 doses of BNT162b2, 36,178,442 doses of mRNA-1273, and 23,093,399 doses of ChAdOx1 were administered across participating sites in the study period. Risk periods following homologous vaccination schedules contributed 23,168,335 person-years of follow-up. OE ratios with LBCI &gt; 1.5 were observed for Guillain-Barré syndrome (2.49, 95 % CI: 2.15, 2.87) and cerebral venous sinus thrombosis (3.23, 95 % CI: 2.51, 4.09) following the first dose of ChAdOx1 vaccine. Acute disseminated encephalomyelitis showed an OE ratio of 3.78 (95 % CI: 1.52, 7.78) following the first dose of mRNA-1273 vaccine. The OE ratios for myocarditis and pericarditis following BNT162b2, mRNA-1273, and ChAdOx1 were significantly increased with LBCIs &gt; 1.5.</p>
<p>Conclusion</p>
<p>This multi-country analysis confirmed pre-established safety signals for myocarditis, pericarditis, Guillain-Barré syndrome, and cerebral venous sinus thrombosis. Other potential safety signals that require further investigation were identified.</p>
<p><strong><a href="/attachments/d3.mock.pdf"><i class="fas fa-file-pdf" style="margin-right: 0.3em;"></i>Download the PDF from VitaminDWiki </a></strong></p>
<p>URL = <a href="https://www.globalvaccinedatanetwork.org/">https://www.globalvaccinedatanetwork.org/</a></p>
<p><strong>Full summary chart</strong></p>
<img src="/attachments/d3.mock.jpg" alt="image" width="600">
<hr>
<h5 id="dr-talked-with-authors-then-made-video-study-did-not-look-at-long-covid-problems">Dr. talked with authors then made video: study did not look at long-COVID problems</h5>
<p><strong><a href="https://www.youtube.com/watch?v=K0Abk5q_z_c&amp;t=22s&amp;ab_channel=DrbeenMedicalLectures">Drbeen</a> 39 minutes</strong></p>
<hr>
<h4 id="vitamindwiki--a-hrefpostscovid-19-treated-by-vitamin-d-studies-reports-videos-stylecolor-red-text-decoration-underline-titlethis-postcategory-does-not-exist-yet-covid-19-treated-by-vitamin-d---studies-reports-videoscovid-19-treated-by-vitamin-d---studies-reports-videosa">VitaminDWiki – <a href="/posts/covid-19-treated-by-vitamin-d-studies-reports-videos" style="color: red; text-decoration: underline;" title="This post/category does not exist yet: COVID-19 treated by Vitamin D - studies, reports, videos">COVID-19 treated by Vitamin D - studies, reports, videos</a></h4>
<ul>
<li>
<img src="https://c19vitamind.com/dsummary.png" alt="image" width="900">
<ul>
<li>The above image is automatically updated</li>
</ul>
</li>
</ul>
<hr>
<h4 id="vitamindwiki---covid-infections-and-vaccinations-decrease-vitamin-d--many-studiespostscovid-infections-and-vaccinations-decrease-vitamin-d-many-studies">VitaminDWiki - <a href="/posts/covid-infections-and-vaccinations-decrease-vitamin-d-many-studies">COVID infections and vaccinations decrease Vitamin D – many studies</a></h4>
<hr>
<h4 id="vitamindwiki-273-a-hrefpostsvaccination-pages-in-vitamindwiki-stylecolor-red-text-decoration-underline-titlethis-postcategory-does-not-exist-yet-vaccination-pages-in-vitamindwikivaccination-pages-in-vitamindwikia">VitaminDWiki: 273+ <a href="/posts/vaccination-pages-in-vitamindwiki" style="color: red; text-decoration: underline;" title="This post/category does not exist yet: Vaccination pages in VitaminDWiki">Vaccination pages in VitaminDWiki</a></h4>
<pre style="background-color: #e0e0e0;">
<code class="language-text">
Markdown:
--------

&lt;!-- {maketoc Title=&quot;&quot;} --&gt;

---

#### COVID-19 vaccines and adverse events of special interest: A multinational Global Vaccine Data Network (GVDN) cohort study of 99 million vaccinated individuals

Vaccine https://doi.org/10.1016/j.vaccine.2024.01.100

K. Faksova a, D. Walsh b c, Y. Jiang b c, J. Griffin c, A. Phillips d, A. Gentile e, J.C. Kwong f g h, K. Macartney d i, M. Naus j n, Z. Grange k, S. Escolano l, G. Sepulveda m, A. Shetty m, A. Pillsbury d, C. Sullivan k, Z. Naveed j n, N.Z. Janjua j n, N. Giglio e, J. Perälä o, S. Nasreen f p x…A. Hviid a w

 **This summary is NOT in the PDF** 

&lt;img src=&quot;/attachments/d3.mock.jpg&quot; alt=&quot;image&quot; width=&quot;300&quot;&gt;

Major color groups used for different pharmas: 

 &amp;nbsp;&amp;nbsp;  &lt;span style=&quot;color:orange;&quot;&gt;Red = Moderna&lt;/span&gt;,  &lt;span style=&quot;color:orange;&quot;&gt;Blue = Pfizer,&lt;/span&gt;  &lt;span style=&quot;color:orange;&quot;&gt;Amber = AstraZeneca&lt;/span&gt;

Shades within the groups related to different doses of the particular pharma&#39;s &quot;vaccine&quot;

&lt;img src=&quot;/attachments/d3.mock.jpg&quot; alt=&quot;image&quot; width=&quot;350&quot;&gt;

Background

The Global COVID Vaccine Safety (GCoVS) Project, established in 2021 under the multinational Global Vaccine Data Network™ (GVDN®), facilitates comprehensive assessment of vaccine safety. This study aimed to evaluate the risk of adverse events of special interest (AESI) following COVID-19 vaccination from 10 sites across eight countries.

Methods

Using a common protocol, this observational cohort study compared observed with expected rates of 13 selected AESI across neurological, haematological, and cardiac outcomes. Expected rates were obtained by participating sites using pre-COVID-19 vaccination healthcare data stratified by age and sex. Observed rates were reported from the same healthcare datasets since COVID-19 vaccination program rollout. AESI occurring up to 42 days following vaccination with mRNA (BNT162b2 and mRNA-1273) and adenovirus-vector (ChAdOx1) vaccines were included in the primary analysis. Risks were assessed using observed versus expected (OE) ratios with 95 % confidence intervals. Prioritised potential safety signals were those with  **lower bound of the 95 % confidence interval (LBCI) greater than 1.5.** 

Results

Participants included 99,068,901 vaccinated individuals. In total, 183,559,462 doses of BNT162b2, 36,178,442 doses of mRNA-1273, and 23,093,399 doses of ChAdOx1 were administered across participating sites in the study period. Risk periods following homologous vaccination schedules contributed 23,168,335 person-years of follow-up. OE ratios with LBCI &gt; 1.5 were observed for Guillain-Barré syndrome (2.49, 95 % CI: 2.15, 2.87) and cerebral venous sinus thrombosis (3.23, 95 % CI: 2.51, 4.09) following the first dose of ChAdOx1 vaccine. Acute disseminated encephalomyelitis showed an OE ratio of 3.78 (95 % CI: 1.52, 7.78) following the first dose of mRNA-1273 vaccine. The OE ratios for myocarditis and pericarditis following BNT162b2, mRNA-1273, and ChAdOx1 were significantly increased with LBCIs &gt; 1.5.

Conclusion

This multi-country analysis confirmed pre-established safety signals for myocarditis, pericarditis, Guillain-Barré syndrome, and cerebral venous sinus thrombosis. Other potential safety signals that require further investigation were identified.

 **[&lt;i class=&quot;fas fa-file-pdf&quot; style=&quot;margin-right: 0.3em;&quot;&gt;&lt;/i&gt;Download the PDF from VitaminDWiki ](/attachments/d3.mock.pdf)** 

URL = [https://www.globalvaccinedatanetwork.org/](https://www.globalvaccinedatanetwork.org/)

 **Full summary chart** 

&lt;img src=&quot;/attachments/d3.mock.jpg&quot; alt=&quot;image&quot; width=&quot;600&quot;&gt;

---

##### Dr. talked with authors then made video: study did not look at long-COVID problems

 **[Drbeen](https://www.youtube.com/watch?v=K0Abk5q_z_c&amp;t=22s&amp;ab_channel=DrbeenMedicalLectures) 39 minutes** 

---

#### VitaminDWiki – &lt;a href=&quot;/posts/covid-19-treated-by-vitamin-d-studies-reports-videos&quot; style=&quot;color: red; text-decoration: underline;&quot; title=&quot;This post/category does not exist yet: COVID-19 treated by Vitamin D - studies, reports, videos&quot;&gt;COVID-19 treated by Vitamin D - studies, reports, videos&lt;/a&gt;

* &lt;img src=&quot;https://c19vitamind.com/dsummary.png&quot; alt=&quot;image&quot; width=&quot;900&quot;&gt;

  * The above image is automatically updated

---

#### VitaminDWiki - [COVID infections and vaccinations decrease Vitamin D – many studies](/posts/covid-infections-and-vaccinations-decrease-vitamin-d-many-studies)

  

---

#### VitaminDWiki: 273+ &lt;a href=&quot;/posts/vaccination-pages-in-vitamindwiki&quot; style=&quot;color: red; text-decoration: underline;&quot; title=&quot;This post/category does not exist yet: Vaccination pages in VitaminDWiki&quot;&gt;Vaccination pages in VitaminDWiki&lt;/a&gt;



AST Structure:
-------------
├── DivNode
│   full_match: `{DIV(class=&quot;lefth4&quot;)}{maketoc Title=&quot;&quot;}{DIV}`
│   inner_content: `{maketoc Title=&quot;&quot;}`
│   attrs_dict:
│   │   raw_content: (class=&quot;lefth4&quot;)
│   │   class: lefth4
│   children:
│   ├── MakeTocNode
│   │   full_match: `{maketoc Title=&quot;&quot;}`
│   │   inner_content: ``
│   │   attrs_dict:
│   │   │   raw_content:  Title=&quot;&quot;
│   │   │   Title: ├── HorizontalRuleNode
│   full_match: `\n---\n`
│   inner_content: `---`├── HeadingNode
│   full_match: `!!!!COVID-19 vaccines and adverse events of special interest: A multinational Global Vaccine Data Network (GVDN) cohort study of 99 million vaccinated individuals`
│   inner_content: `COVID-19 vaccines and adverse events of special interest: A multinational Global Vaccine Data Network (GVDN) cohort study of 99 million vaccinated individuals`
│   level: `4`
│   children:
│   ├── TextNode
│   │   full_match: `COVID-19 vaccines and adverse events of special interest: A multinational Global Vaccine Data Network (GVDN) cohort study of 99 million vaccinated individuals`
│   │   inner_content: `COVID-19 vaccines and adverse events of special interest: A multinational Global Vaccine Data Network (GVDN) cohort study of 99 million vaccinated individuals`├── TextNode
│   full_match: `\nVaccine https://doi.org/10.1016/j.vaccine.2024.01.100\nK. Faksova a, D. Walsh b c, Y. Jiang b c, J. Griffin c, A. Phillips d, A. Gentile e, J.C. Kwong f g h, K. Macartney d i, M. Naus j n, Z. Grange k, S. Escolano l, G. Sepulveda m, A. Shetty m, A. Pillsbury d, C. Sullivan k, Z. Naveed j n, N.Z. Janjua j n, N. Giglio e, J. Perälä o, S. Nasreen f p x…A. Hviid a w\n\n`
│   inner_content: `\nVaccine https://doi.org/10.1016/j.vaccine.2024.01.100\nK. Faksova a, D. Walsh b c, Y. Jiang b c, J. Griffin c, A. Phillips d, A. Gentile e, J.C. Kwong f g h, K. Macartney d i, M. Naus j n, Z. Grange k, S. Escolano l, G. Sepulveda m, A. Shetty m, A. Pillsbury d, C. Sullivan k, Z. Naveed j n, N.Z. Janjua j n, N. Giglio e, J. Perälä o, S. Nasreen f p x…A. Hviid a w\n\n`├── BoldNode
│   full_match: `__This summary is NOT in the PDF__`
│   inner_content: `This summary is NOT in the PDF`
│   children:
│   ├── TextNode
│   │   full_match: `This summary is NOT in the PDF`
│   │   inner_content: `This summary is NOT in the PDF`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ImgNode
│   full_match: `{img type=&quot;attId&quot; attId=&quot;20953&quot; width=&quot;300&quot;}`
│   inner_content: ``
│   attrs_dict:
│   │   raw_content:  type=&quot;attId&quot; attId=&quot;20953&quot; width=&quot;300&quot;
│   │   type: attId
│   │   attId: 20953
│   │   width: 300├── TextNode
│   full_match: `\nMajor color groups used for different pharmas: \n `
│   inner_content: `\nMajor color groups used for different pharmas: \n `├── HorizontalSpaceNode
│   full_match: `~hs~~hs~`
│   inner_content: ``
│   repetitions: `2`├── TextNode
│   full_match: ` `
│   inner_content: ` `├── ColorNode
│   full_match: `~~#F06:Red = Moderna~~`
│   inner_content: `Red = Moderna`
│   attrs_dict:
│   │   raw_content: #F06
│   children:
│   ├── TextNode
│   │   full_match: `Red = Moderna`
│   │   inner_content: `Red = Moderna`├── TextNode
│   full_match: `, `
│   inner_content: `, `├── ColorNode
│   full_match: `~~#00F:Blue = Pfizer,~~`
│   inner_content: `Blue = Pfizer,`
│   attrs_dict:
│   │   raw_content: #00F
│   children:
│   ├── TextNode
│   │   full_match: `Blue = Pfizer,`
│   │   inner_content: `Blue = Pfizer,`├── TextNode
│   full_match: ` `
│   inner_content: ` `├── ColorNode
│   full_match: `~~#F96:Amber = AstraZeneca~~`
│   inner_content: `Amber = AstraZeneca`
│   attrs_dict:
│   │   raw_content: #F96
│   children:
│   ├── TextNode
│   │   full_match: `Amber = AstraZeneca`
│   │   inner_content: `Amber = AstraZeneca`├── TextNode
│   full_match: `\nShades within the groups related to different doses of the particular pharma&#39;s &quot;vaccine&quot;\n\n`
│   inner_content: `\nShades within the groups related to different doses of the particular pharma&#39;s &quot;vaccine&quot;\n\n`├── ImgNode
│   full_match: `{img type=&quot;attId&quot; attId=&quot;20954&quot; width=&quot;350&quot;}`
│   inner_content: ``
│   attrs_dict:
│   │   raw_content:  type=&quot;attId&quot; attId=&quot;20954&quot; width=&quot;350&quot;
│   │   type: attId
│   │   attId: 20954
│   │   width: 350├── TextNode
│   full_match: `\nBackground\nThe Global COVID Vaccine Safety (GCoVS) Project, established in 2021 under the multinational Global Vaccine Data Network™ (GVDN®), facilitates comprehensive assessment of vaccine safety. This study aimed to evaluate the risk of adverse events of special interest (AESI) following COVID-19 vaccination from 10 sites across eight countries.\n\nMethods\nUsing a common protocol, this observational cohort study compared observed with expected rates of 13 selected AESI across neurological, haematological, and cardiac outcomes. Expected rates were obtained by participating sites using pre-COVID-19 vaccination healthcare data stratified by age and sex. Observed rates were reported from the same healthcare datasets since COVID-19 vaccination program rollout. AESI occurring up to 42 days following vaccination with mRNA (BNT162b2 and mRNA-1273) and adenovirus-vector (ChAdOx1) vaccines were included in the primary analysis. Risks were assessed using observed versus expected (OE) ratios with 95 % confidence intervals. Prioritised potential safety signals were those with `
│   inner_content: `\nBackground\nThe Global COVID Vaccine Safety (GCoVS) Project, established in 2021 under the multinational Global Vaccine Data Network™ (GVDN®), facilitates comprehensive assessment of vaccine safety. This study aimed to evaluate the risk of adverse events of special interest (AESI) following COVID-19 vaccination from 10 sites across eight countries.\n\nMethods\nUsing a common protocol, this observational cohort study compared observed with expected rates of 13 selected AESI across neurological, haematological, and cardiac outcomes. Expected rates were obtained by participating sites using pre-COVID-19 vaccination healthcare data stratified by age and sex. Observed rates were reported from the same healthcare datasets since COVID-19 vaccination program rollout. AESI occurring up to 42 days following vaccination with mRNA (BNT162b2 and mRNA-1273) and adenovirus-vector (ChAdOx1) vaccines were included in the primary analysis. Risks were assessed using observed versus expected (OE) ratios with 95 % confidence intervals. Prioritised potential safety signals were those with `├── BoldNode
│   full_match: `__lower bound of the 95 % confidence interval (LBCI) greater than 1.5.__`
│   inner_content: `lower bound of the 95 % confidence interval (LBCI) greater than 1.5.`
│   children:
│   ├── TextNode
│   │   full_match: `lower bound of the 95 % confidence interval (LBCI) greater than 1.5.`
│   │   inner_content: `lower bound of the 95 % confidence interval (LBCI) greater than 1.5.`├── TextNode
│   full_match: `\n\nResults\nParticipants included 99,068,901 vaccinated individuals. In total, 183,559,462 doses of BNT162b2, 36,178,442 doses of mRNA-1273, and 23,093,399 doses of ChAdOx1 were administered across participating sites in the study period. Risk periods following homologous vaccination schedules contributed 23,168,335 person-years of follow-up. OE ratios with LBCI &gt; 1.5 were observed for Guillain-Barré syndrome (2.49, 95 % CI: 2.15, 2.87) and cerebral venous sinus thrombosis (3.23, 95 % CI: 2.51, 4.09) following the first dose of ChAdOx1 vaccine. Acute disseminated encephalomyelitis showed an OE ratio of 3.78 (95 % CI: 1.52, 7.78) following the first dose of mRNA-1273 vaccine. The OE ratios for myocarditis and pericarditis following BNT162b2, mRNA-1273, and ChAdOx1 were significantly increased with LBCIs &gt; 1.5.\n\nConclusion\nThis multi-country analysis confirmed pre-established safety signals for myocarditis, pericarditis, Guillain-Barré syndrome, and cerebral venous sinus thrombosis. Other potential safety signals that require further investigation were identified.\n`
│   inner_content: `\n\nResults\nParticipants included 99,068,901 vaccinated individuals. In total, 183,559,462 doses of BNT162b2, 36,178,442 doses of mRNA-1273, and 23,093,399 doses of ChAdOx1 were administered across participating sites in the study period. Risk periods following homologous vaccination schedules contributed 23,168,335 person-years of follow-up. OE ratios with LBCI &gt; 1.5 were observed for Guillain-Barré syndrome (2.49, 95 % CI: 2.15, 2.87) and cerebral venous sinus thrombosis (3.23, 95 % CI: 2.51, 4.09) following the first dose of ChAdOx1 vaccine. Acute disseminated encephalomyelitis showed an OE ratio of 3.78 (95 % CI: 1.52, 7.78) following the first dose of mRNA-1273 vaccine. The OE ratios for myocarditis and pericarditis following BNT162b2, mRNA-1273, and ChAdOx1 were significantly increased with LBCIs &gt; 1.5.\n\nConclusion\nThis multi-country analysis confirmed pre-established safety signals for myocarditis, pericarditis, Guillain-Barré syndrome, and cerebral venous sinus thrombosis. Other potential safety signals that require further investigation were identified.\n`├── FontNode
│   full_match: `{FONT(size=&quot;18&quot;)}__{ATTACH(inline=&quot;1&quot; id=&quot;20952&quot; icon=&quot;1&quot;)}Download the PDF from VitaminDWiki {ATTACH}__{FONT}`
│   inner_content: `__{ATTACH(inline=&quot;1&quot; id=&quot;20952&quot; icon=&quot;1&quot;)}Download the PDF from VitaminDWiki {ATTACH}__`
│   attrs_dict:
│   │   raw_content: size=&quot;18&quot;
│   │   size: 18
│   children:
│   ├── BoldNode
│   │   full_match: `__{ATTACH(inline=&quot;1&quot; id=&quot;20952&quot; icon=&quot;1&quot;)}Download the PDF from VitaminDWiki {ATTACH}__`
│   │   inner_content: `{ATTACH(inline=&quot;1&quot; id=&quot;20952&quot; icon=&quot;1&quot;)}Download the PDF from VitaminDWiki {ATTACH}`
│   │   children:
│   │   ├── AttachNode
│   │   │   full_match: `{ATTACH(inline=&quot;1&quot; id=&quot;20952&quot; icon=&quot;1&quot;)}Download the PDF from VitaminDWiki {ATTACH}`
│   │   │   inner_content: `Download the PDF from VitaminDWiki `
│   │   │   attrs_dict:
│   │   │   │   raw_content: (inline=&quot;1&quot; id=&quot;20952&quot; icon=&quot;1&quot;)
│   │   │   │   inline: 1
│   │   │   │   id: 20952
│   │   │   │   icon: 1
│   │   │   children:
│   │   │   ├── TextNode
│   │   │   │   full_match: `Download the PDF from VitaminDWiki `
│   │   │   │   inner_content: `Download the PDF from VitaminDWiki `├── TextNode
│   full_match: `\n\n`
│   inner_content: `\n\n`├── FontNode
│   full_match: `{FONT(size=&quot;18&quot;)}URL = [https://www.globalvaccinedatanetwork.org/]{FONT}`
│   inner_content: `URL = [https://www.globalvaccinedatanetwork.org/]`
│   attrs_dict:
│   │   raw_content: size=&quot;18&quot;
│   │   size: 18
│   children:
│   ├── TextNode
│   │   full_match: `URL = `
│   │   inner_content: `URL = `
│   ├── LinkNode
│   │   full_match: `[https://www.globalvaccinedatanetwork.org/]`
│   │   inner_content: `https://www.globalvaccinedatanetwork.org/`
│   │   url: `https://www.globalvaccinedatanetwork.org/`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `https://www.globalvaccinedatanetwork.org/`
│   │   │   inner_content: `https://www.globalvaccinedatanetwork.org/`├── TextNode
│   full_match: `\n\n`
│   inner_content: `\n\n`├── BoldNode
│   full_match: `__Full summary chart__`
│   inner_content: `Full summary chart`
│   children:
│   ├── TextNode
│   │   full_match: `Full summary chart`
│   │   inner_content: `Full summary chart`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ImgNode
│   full_match: `{img type=&quot;attId&quot; attId=&quot;20955&quot; width=&quot;600&quot;}`
│   inner_content: ``
│   attrs_dict:
│   │   raw_content:  type=&quot;attId&quot; attId=&quot;20955&quot; width=&quot;600&quot;
│   │   type: attId
│   │   attId: 20955
│   │   width: 600├── HorizontalRuleNode
│   full_match: `\n---\n`
│   inner_content: `---`├── HeadingNode
│   full_match: `!!!!!Dr. talked with authors then made video: study did not look at long-COVID problems`
│   inner_content: `Dr. talked with authors then made video: study did not look at long-COVID problems`
│   level: `5`
│   children:
│   ├── TextNode
│   │   full_match: `Dr. talked with authors then made video: study did not look at long-COVID problems`
│   │   inner_content: `Dr. talked with authors then made video: study did not look at long-COVID problems`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── BoldNode
│   full_match: `__[https://www.youtube.com/watch?v=K0Abk5q_z_c&amp;t=22s&amp;ab_channel=DrbeenMedicalLectures|Drbeen] 39 minutes__`
│   inner_content: `[https://www.youtube.com/watch?v=K0Abk5q_z_c&amp;t=22s&amp;ab_channel=DrbeenMedicalLectures|Drbeen] 39 minutes`
│   children:
│   ├── LinkNode
│   │   full_match: `[https://www.youtube.com/watch?v=K0Abk5q_z_c&amp;t=22s&amp;ab_channel=DrbeenMedicalLectures|Drbeen]`
│   │   inner_content: `Drbeen`
│   │   url: `https://www.youtube.com/watch?v=K0Abk5q_z_c&amp;t=22s&amp;ab_channel=DrbeenMedicalLectures`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `Drbeen`
│   │   │   inner_content: `Drbeen`
│   ├── TextNode
│   │   full_match: ` 39 minutes`
│   │   inner_content: ` 39 minutes`├── HorizontalRuleNode
│   full_match: `\n---\n`
│   inner_content: `---`├── HeadingNode
│   full_match: `!!!!VitaminDWiki – ((COVID-19 treated by Vitamin D - studies, reports, videos))`
│   inner_content: `VitaminDWiki – ((COVID-19 treated by Vitamin D - studies, reports, videos))`
│   level: `4`
│   children:
│   ├── TextNode
│   │   full_match: `VitaminDWiki – `
│   │   inner_content: `VitaminDWiki – `
│   ├── LocalLinkNode
│   │   full_match: `((COVID-19 treated by Vitamin D - studies, reports, videos))`
│   │   inner_content: `COVID-19 treated by Vitamin D - studies, reports, videos`
│   │   page: `COVID-19 treated by Vitamin D - studies, reports, videos`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `COVID-19 treated by Vitamin D - studies, reports, videos`
│   │   │   inner_content: `COVID-19 treated by Vitamin D - studies, reports, videos`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── IncludeNode
│   full_match: `{include page=&quot;COVID-19 treated by Vitamin D - studies, reports, videos&quot; start=&quot;~tc~ startsum ~/tc~&quot; stop=&quot;~tc~ endsum ~/tc~&quot;}`
│   inner_content: ``
│   attrs_dict:
│   │   raw_content:  page=&quot;COVID-19 treated by Vitamin D - studies, reports, videos&quot; start=&quot;~tc~ startsum ~/tc~&quot; stop=&quot;~tc~ endsum ~/tc~&quot;
│   │   page: COVID-19 treated by Vitamin D - studies, reports, videos
│   │   start: ~tc~ startsum ~/tc~
│   │   stop: ~tc~ endsum ~/tc~
│   children:
│   ├── TextNode
│   │   full_match: ``
│   │   inner_content: ``├── TextNode
│   full_match: `\n\n`
│   inner_content: `\n\n`├── ListItemNode
│   full_match: `*{img type=&quot;src&quot; src=&quot;https://c19vitamind.com/dsummary.png&quot; width=&quot;900&quot;}`
│   inner_content: `{img type=&quot;src&quot; src=&quot;https://c19vitamind.com/dsummary.png&quot; width=&quot;900&quot;}`
│   depth: `1`
│   children:
│   ├── ImgNode
│   │   full_match: `{img type=&quot;src&quot; src=&quot;https://c19vitamind.com/dsummary.png&quot; width=&quot;900&quot;}`
│   │   inner_content: ``
│   │   attrs_dict:
│   │   │   raw_content:  type=&quot;src&quot; src=&quot;https://c19vitamind.com/dsummary.png&quot; width=&quot;900&quot;
│   │   │   type: src
│   │   │   src: https://c19vitamind.com/dsummary.png
│   │   │   width: 900├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `**The above image is automatically updated`
│   inner_content: `The above image is automatically updated`
│   depth: `2`
│   children:
│   ├── TextNode
│   │   full_match: `The above image is automatically updated`
│   │   inner_content: `The above image is automatically updated`├── HorizontalRuleNode
│   full_match: `\n---\n`
│   inner_content: `---`├── HeadingNode
│   full_match: `!!!!VitaminDWiki - ((COVID infections and vaccinations decrease Vitamin D – many studies))`
│   inner_content: `VitaminDWiki - ((COVID infections and vaccinations decrease Vitamin D – many studies))`
│   level: `4`
│   children:
│   ├── TextNode
│   │   full_match: `VitaminDWiki - `
│   │   inner_content: `VitaminDWiki - `
│   ├── LocalLinkNode
│   │   full_match: `((COVID infections and vaccinations decrease Vitamin D – many studies))`
│   │   inner_content: `COVID infections and vaccinations decrease Vitamin D – many studies`
│   │   page: `COVID infections and vaccinations decrease Vitamin D – many studies`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `COVID infections and vaccinations decrease Vitamin D – many studies`
│   │   │   inner_content: `COVID infections and vaccinations decrease Vitamin D – many studies`├── TextNode
│   full_match: `\n  `
│   inner_content: `\n  `├── IncludeNode
│   full_match: `{include page=&quot;COVID infections and vaccinations decrease Vitamin D – many studies&quot;}`
│   inner_content: ``
│   attrs_dict:
│   │   raw_content:  page=&quot;COVID infections and vaccinations decrease Vitamin D – many studies&quot;
│   │   page: COVID infections and vaccinations decrease Vitamin D – many studies
│   children:
│   ├── TextNode
│   │   full_match: ``
│   │   inner_content: ``├── HorizontalRuleNode
│   full_match: `\n---\n`
│   inner_content: `---`├── HeadingNode
│   full_match: `!!!!VitaminDWiki: 273+ ((Vaccination pages in VitaminDWiki))`
│   inner_content: `VitaminDWiki: 273+ ((Vaccination pages in VitaminDWiki))`
│   level: `4`
│   children:
│   ├── TextNode
│   │   full_match: `VitaminDWiki: 273+ `
│   │   inner_content: `VitaminDWiki: 273+ `
│   ├── LocalLinkNode
│   │   full_match: `((Vaccination pages in VitaminDWiki))`
│   │   inner_content: `Vaccination pages in VitaminDWiki`
│   │   page: `Vaccination pages in VitaminDWiki`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `Vaccination pages in VitaminDWiki`
│   │   │   inner_content: `Vaccination pages in VitaminDWiki`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`

Original Tiki:
-------------
{DIV(class=&quot;lefth4&quot;)}{maketoc Title=&quot;&quot;}{DIV}
---
!!!!COVID-19 vaccines and adverse events of special interest: A multinational Global Vaccine Data Network (GVDN) cohort study of 99 million vaccinated individuals
Vaccine https://doi.org/10.1016/j.vaccine.2024.01.100
K. Faksova a, D. Walsh b c, Y. Jiang b c, J. Griffin c, A. Phillips d, A. Gentile e, J.C. Kwong f g h, K. Macartney d i, M. Naus j n, Z. Grange k, S. Escolano l, G. Sepulveda m, A. Shetty m, A. Pillsbury d, C. Sullivan k, Z. Naveed j n, N.Z. Janjua j n, N. Giglio e, J. Perälä o, S. Nasreen f p x…A. Hviid a w

__This summary is NOT in the PDF__
{img type=&quot;attId&quot; attId=&quot;20953&quot; width=&quot;300&quot;}
Major color groups used for different pharmas: 
 ~hs~~hs~ ~~#F06:Red = Moderna~~, ~~#00F:Blue = Pfizer,~~ ~~#F96:Amber = AstraZeneca~~
Shades within the groups related to different doses of the particular pharma&#39;s &quot;vaccine&quot;

{img type=&quot;attId&quot; attId=&quot;20954&quot; width=&quot;350&quot;}
Background
The Global COVID Vaccine Safety (GCoVS) Project, established in 2021 under the multinational Global Vaccine Data Network™ (GVDN®), facilitates comprehensive assessment of vaccine safety. This study aimed to evaluate the risk of adverse events of special interest (AESI) following COVID-19 vaccination from 10 sites across eight countries.

Methods
Using a common protocol, this observational cohort study compared observed with expected rates of 13 selected AESI across neurological, haematological, and cardiac outcomes. Expected rates were obtained by participating sites using pre-COVID-19 vaccination healthcare data stratified by age and sex. Observed rates were reported from the same healthcare datasets since COVID-19 vaccination program rollout. AESI occurring up to 42 days following vaccination with mRNA (BNT162b2 and mRNA-1273) and adenovirus-vector (ChAdOx1) vaccines were included in the primary analysis. Risks were assessed using observed versus expected (OE) ratios with 95 % confidence intervals. Prioritised potential safety signals were those with __lower bound of the 95 % confidence interval (LBCI) greater than 1.5.__

Results
Participants included 99,068,901 vaccinated individuals. In total, 183,559,462 doses of BNT162b2, 36,178,442 doses of mRNA-1273, and 23,093,399 doses of ChAdOx1 were administered across participating sites in the study period. Risk periods following homologous vaccination schedules contributed 23,168,335 person-years of follow-up. OE ratios with LBCI &gt; 1.5 were observed for Guillain-Barré syndrome (2.49, 95 % CI: 2.15, 2.87) and cerebral venous sinus thrombosis (3.23, 95 % CI: 2.51, 4.09) following the first dose of ChAdOx1 vaccine. Acute disseminated encephalomyelitis showed an OE ratio of 3.78 (95 % CI: 1.52, 7.78) following the first dose of mRNA-1273 vaccine. The OE ratios for myocarditis and pericarditis following BNT162b2, mRNA-1273, and ChAdOx1 were significantly increased with LBCIs &gt; 1.5.

Conclusion
This multi-country analysis confirmed pre-established safety signals for myocarditis, pericarditis, Guillain-Barré syndrome, and cerebral venous sinus thrombosis. Other potential safety signals that require further investigation were identified.
{FONT(size=&quot;18&quot;)}__{ATTACH(inline=&quot;1&quot; id=&quot;20952&quot; icon=&quot;1&quot;)}Download the PDF from VitaminDWiki {ATTACH}__{FONT}

{FONT(size=&quot;18&quot;)}URL = [https://www.globalvaccinedatanetwork.org/]{FONT}

__Full summary chart__
{img type=&quot;attId&quot; attId=&quot;20955&quot; width=&quot;600&quot;}
---
!!!!!Dr. talked with authors then made video: study did not look at long-COVID problems
__[https://www.youtube.com/watch?v=K0Abk5q_z_c&amp;t=22s&amp;ab_channel=DrbeenMedicalLectures|Drbeen] 39 minutes__
---
!!!!VitaminDWiki – ((COVID-19 treated by Vitamin D - studies, reports, videos))
{include page=&quot;COVID-19 treated by Vitamin D - studies, reports, videos&quot; start=&quot;~tc~ startsum ~/tc~&quot; stop=&quot;~tc~ endsum ~/tc~&quot;}

*{img type=&quot;src&quot; src=&quot;https://c19vitamind.com/dsummary.png&quot; width=&quot;900&quot;}
**The above image is automatically updated
---
!!!!VitaminDWiki - ((COVID infections and vaccinations decrease Vitamin D – many studies))
  {include page=&quot;COVID infections and vaccinations decrease Vitamin D – many studies&quot;}
---
!!!!VitaminDWiki: 273+ ((Vaccination pages in VitaminDWiki))

</code>
</pre>

    </article>

        </div>
    </div>

    <script src="/js/lightspa.js?v=1742566338"></script>
    <script>
        
        const spa = new LightSPA({
            mainContentSelector: '[role="main"]',
            navigationSelector: '[data-spa-nav]'
        });

        
        const search = new Search({
            documentsUrl: '\/js\/search_documents.json?v=1742566338',
            indexUrl: '\/js\/search_index.json?v=1742566338'
        });
    </script>
</body>
</html>